Skip to main content
Expert.Ai logo

Expert.Ai — Investor Relations & Filings

Ticker · EXAI ISIN · IT0004496029 LEI · 815600FD1E3D444B2019 XMIL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 458 across all filing types
Latest filing 2023-01-30 Regulatory Filings
Country IT Italy
Listing XMIL EXAI

About Expert.Ai

https://www.expert.ai

Expert.ai is a developer of enterprise artificial intelligence solutions specializing in Natural Language Processing (NLP) and Understanding (NLU). The company's core offering, the EidenAI Suite, provides tailored solutions for industries including insurance, financial services, life sciences, and the public sector. Its key differentiator is a Hybrid AI approach that combines neuro-symbolic AI, knowledge graphs, and proprietary technology with machine learning, deep learning, and large language models (LLMs). This methodology enables organizations to analyze unstructured data, automate complex processes, mitigate risk, and improve decision-making. The company focuses on delivering scalable, transparent, and reliable AI to generate measurable business value and a high return on investment for its clients.

Recent filings

Filing Released Lang Actions
Corporate events calendar 2023
Regulatory Filings Classification · 1% confidence The document is a formal announcement dated January 30, 2023, titled 'Corporate events calendar 2023'. It lists future dates for key corporate activities such as Board meetings for financial statement approval (including year-end 2022 and half-year 2023 reports), shareholder meetings, and investor webinars. This type of forward-looking schedule announcement, which details when reports (like annual or interim financials) will be released or discussed, does not fit the definitions for the reports themselves (10-K, IR, ER) or specific financial events (DIV, NAV). It is a general corporate update regarding future disclosures and meetings. Since it is a formal regulatory announcement (Informazione Regolamentata) detailing future corporate actions and report publication schedules, it best fits the general 'Regulatory Filings' category (RNS) as a miscellaneous, non-specific disclosure, or potentially a Report Publication Announcement (RPA) if the focus was solely on announcing the *release* of a specific report, but here it is a calendar of multiple events. Given the nature of announcing a calendar of future events, RNS is the most appropriate fallback for a general regulatory disclosure that doesn't match a more specific category.
2023-01-30 English
Calendario eventi societari 2023
Report Publication Announcement Classification · 1% confidence The document is an official regulatory announcement ('Informazione Regolamentata') from Expert.ai, dated January 30, 2023. The subject ('Oggetto') is 'Calendario eventi societari 2023' (Corporate Events Calendar 2023). It lists future dates for Board meetings to approve financial results (March 30, Sept 28), shareholder meetings (May 2/3), and investor webinars. The document explicitly states it is providing information about future events and directs readers to the company website for the full calendar. Since this is an announcement detailing the schedule of future corporate events, and not the actual financial report (like 10-K or IR) or a transcript, it best fits the category for general regulatory announcements or information related to shareholder meetings/corporate governance schedules. Given the options, this is a specific announcement regarding corporate events, which often precedes an AGM or financial release. However, since it is a schedule of events including board meetings and shareholder meetings, it relates closely to governance and future reporting. It is not a proxy statement (PSI), nor a dividend notice (DIV). It is a schedule of key corporate dates. Since it is a formal regulatory filing announcing a schedule, and it doesn't fit perfectly into the specific financial report categories, the most appropriate general category for a formal, scheduled announcement of corporate activities is often 'Regulatory Filings' (RNS) or potentially related to AGM/Governance. Given the content focuses on the schedule of financial reporting approvals and shareholder meetings, and it is a short regulatory notice ('Vedi allegato' implies the main content is the schedule itself), it functions as a general regulatory update. If a specific 'Corporate Calendar' code existed, it would be used. Lacking that, RNS is the best fit for a general regulatory disclosure that doesn't match other specific types, although it is highly related to AGM/IR activities. Given the structure, it is a formal regulatory disclosure of future dates, making RNS the most suitable fallback for a non-standard, scheduled announcement.
2023-01-30 Italian
BoD resolves on capital increase, updates 2022B-2024E Plan, allocates Stock Grant, appoints SB, convenes Ordinary Shareholders’ Meeting
Share Issue/Capital Change Classification · 1% confidence The document is an official communication from Expert.ai, dated January 27, 2023, released via Euronext Growth Milan. The subject line and content detail several significant corporate actions resolved by the Board of Directors: a capital increase, updates to the 2022B-2024E Industrial Plan, allocation of stock grants, appointment of a Supervisory Body, and the convening of an Ordinary Shareholders' Meeting to appoint an auditor. These actions relate to financing (capital increase), strategic outlook (Plan updates), and corporate governance (appointments, meeting notice). Since the document announces multiple material corporate decisions, including financing activities (CAP) and governance changes (MANG/CGR), and it is structured as a formal press release announcing resolutions rather than a full statutory report (like 10-K or IR), it best fits the category for Capital/Financing Updates (CAP) or a general Regulatory Filing (RNS). Given the prominence of the capital increase resolution, CAP is a strong candidate. However, the document also covers management/governance appointments and a notice for a future shareholders' meeting. Because it is a comprehensive announcement of multiple material events, including financing, strategy updates, and governance actions, and it is not a specific statutory report, it functions as a broad regulatory disclosure. Since 'CAP' covers the capital increase, and 'MANG' covers some governance aspects, 'RNS' (Regulatory Filings - general/miscellaneous) is often used for these omnibus press releases detailing board resolutions on various matters, especially when they don't fit perfectly into a single narrow category like 'ER' or 'IR'. However, the capital increase is a primary focus. Let's re-evaluate the options based on the primary content: Capital Increase (CAP), Plan Update (MDA/IP), Meeting Notice (PSI/RPA). Since it's a resolution announcement covering financing, governance, and strategy updates, and it's not a full report, 'CAP' (Capital/Financing Update) captures the most significant financial action announced, or 'RNS' as a catch-all for complex regulatory disclosures. Given the explicit mention of capital increase and option exclusion, 'CAP' is highly relevant. If a single best fit is required, and considering the mix of financing and governance, 'RNS' is the safest general regulatory classification for a complex board resolution announcement, but 'CAP' is very specific to one major item. Since the document is a formal 'Informazione Regolamentata' (Regulated Information) detailing resolutions on capital structure, 'CAP' is appropriate, although 'RNS' would also be defensible as a catch-all. I will select 'CAP' due to the explicit resolution on capital increase.
2023-01-27 English
Il CdA delibera AuCap riservato, aggiorna il BP 22B-24E, assegna Stock Grant, nomina OdV e convoca Assemblea Ordinaria
Share Issue/Capital Change Classification · 1% confidence The document is an official communication from expert.ai, identified by the header "Informazione Regolamentata n. 20040-2-2023" and received on January 27, 2023, on Euronext Growth Milan. The subject ("Oggetto") and the body detail several significant corporate actions: a capital increase reserved for a specific purpose, an update to the industrial plan (2022B-2024E), the convocation of an Ordinary Shareholders' Meeting (Assemblea Ordinaria) to appoint the statutory auditor, the assignment of Stock Grants, and the appointment of the Supervisory Body (Organismo di Vigilanza). These actions—capital changes, management/governance updates, and financial outlook revisions—are typically bundled into a comprehensive press release or regulatory disclosure. Since it announces multiple material events (Capital increase/SHA, Industrial Plan update/MDA, Meeting convocation/AGM-R related, Stock Grant/CAP related), it is not a single specific report like 10-K or IR. It is a broad regulatory disclosure. Given the nature of the announcements (capital increase, stock grants, governance changes), it fits best under a general regulatory announcement or a combination of types. However, since it is a formal, comprehensive disclosure of multiple material events required by market regulations, and it is not merely announcing the publication of a separate report (Rule 2), it is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) due to the prominent capital increase. Since it covers governance, financing, and outlook updates, RNS serves as the most appropriate catch-all for a complex, multi-topic regulatory press release that doesn't fit perfectly into the narrower categories like ER or IR. The document is substantial (over 10,000 characters) and contains the substance, not just a link to it.
2023-01-27 Italian
Comunicazione di variazione del capitale sociale a conclusione dell'aumento di capitale
Share Issue/Capital Change Classification · 1% confidence The document is an official communication ('Informazione Regolamentata') from EXPERT.AI dated January 11, 2023. The subject ('Oggetto') explicitly states: 'Comunicazione di variazione del capitale sociale a conclusione dell'aumento di capitale' (Communication of change in share capital following the capital increase). The text details the new number of shares, the change in total capital value, and the resulting shareholder structure after a capital increase operation. This directly relates to changes in the company's capital structure and financing activities. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV).
2023-01-11 Italian
Risultati definitivi dell'aumento di capitale
Capital/Financing Update Classification · 1% confidence The document is an official communication titled "Expert.ai: risultati definitivi dell'aumento di capitale" (Expert.ai: final results of the capital increase). It details the subscription results of a capital increase, the resulting new share count, and the updated shareholder structure. This content directly relates to fundraising, financing activities, and capital structure changes. According to the definitions, this aligns perfectly with the 'Capital/Financing Update' category (Code: CAP). Although it mentions the final results, it is the primary announcement of the capital change outcome, not just a notice that a report is attached (which would suggest RPA or RNS).
2022-12-30 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.